Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

40611 - 40620 of 57753 results found

Broadly neutralizing antibodies against COVID-19

Date
Wednesday, June 07, 2023 - 4:00 AM
Description
The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an effective treatment. Since SARS-CoV-2 emerged, a variety of strains have acquired

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy

Date
Wednesday, June 07, 2023 - 4:00 AM
Description
COVID-19 patients at risk of severe disease may be treated with neutralising monoclonal antibodies (mAbs). To minimise virus escape from neutralisation these are administered as combinations e.g. casirivimab+imdevimab or, for antibodies targeting